Viamet Pharmaceuticals
Business Services · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4505 Emperor Blvd Ste 300, Durham, North...Phone Number
(919) 467-8539Website
www.viamet.comRevenue
$11.8 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Viamet Pharmaceuticals
Metaverde, LLC is an innovation hub led by Michael Von Irvin, focusing on revolutionizing healthcare, education, safety, energy, and technology through advanced solutions. The company offers a range of services including AI training for healthcare professionals, education and skill development platforms, fire protection services, and infrastructure development. With a commitment to leveraging AI for real-world challenges, Metaverde aims to connect with visionaries to shape the future. The company operates multiple ventures, including Aivala, which addresses care coordination gaps, and various platforms for economic insights and wellness innovations.Explore more
Viamet Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Viamet Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Viamet Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Viamet Pharmaceuticals
Product Launch: Get notified when Viamet Pharmaceuticals launches new products
Earning: See what the market has to say on Viamet Pharmaceuticals recently announced quarterly report
Check out if Viamet Pharmaceuticals is spiking on competitors!
Click to see if Viamet Pharmaceuticals had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Viamet Pharmaceuticals has new funding data
Viamet Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Viamet Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Viamet Pharmaceuticals
Compare insights from companies similar to Viamet Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Viamet Pharmaceuticals
$11.8M
11-50
Private
$155.5M
2005
SB
Stephen BrandVice President, Clinical Development
Company Profile Activity
Activity Insights
Viamet Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Viamet Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Viamet Pharmaceuticals.
Viamet Pharmaceuticals financials insights
Gather financial insights about Viamet Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Series A
$4M
2009
Private Equity
$10M
Series B
$18M
2011
Private Equity
$39.6M
2014
Series C
$10M
Series D
$60M
2015
Grant
$1.9M
2016
Private Equity
$12M
Viamet Pharmaceuticals Tech Stack
A closer look at the technologies used by Viamet Pharmaceuticals
See more technologies
Most Recent Scoops
Left Company
Executive Move
Volker Herrmann, Chief Commercial Officer, has left the organization to serve as Chief Operating Officer & President at SQZ.
Executive Moves, Personnel Moves, Left Company
Mergers & Acquisitions (M&A)
Viamet Pharmaceuticals announced that Patrick Jordan, a Partner at NovaQuest Capital Management, will assume the role of Interim Chief Executive Officer following the company's acquisition by NovaQuest.
Recruitment
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
Funding
Viamet Pharmaceuticals recently secured $12 million in an unknown Series funding round.
Funding
Funding
Funding
Viamet Pharmaceuticals News & Media
NovaQuest Capital to buy Viamet Pharmaceuticals
NovaQuest Capital Management has agreed to acquire drug developer Viamet Pharmaceuticals. No financial terms were disclosed. Patrick Jordan, a partner at NovaQuest Capital, will become Viamet's interim CEO while Dr. Robert Schotzinger will remain as president and CEO of the Viamet group of companies.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Viamet Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Metaverde, LLC is an innovation hub led by Michael Von Irvin, focusing on revolutionizing healthcare, education, safety, energy, and technology through advanced solutions. The company offers a range of services including AI training for healthcare professionals, education and skill development platforms, fire protection services, and infrastructure... Read More
